HopeStage
Back to all studies
CompletedNCT04951076

BNC210 for adults with PTSD: a placebo-controlled study

About this title

A Phase 2b Study of BNC210 Tablet Formulation in Adults With Post-Traumatic Stress Disorder (PTSD)

Read the official source — NCT04951076

Researchers compared BNC210 and placebo to find out how the approaches affected post-traumatic stress symptoms in adults with PTSD.

Medication studyAges 18–75United States + United Kingdom
The study in practice

Understand this study

What did researchers investigate?

Researchers compared BNC210 and placebo to find out how the approaches affected post-traumatic stress symptoms in adults with PTSD.

Who was this study for?

This study was for people with PTSD. Listed age limits: 18 years to 75 years. Other eligibility criteria applied.

Listed locations
Bellflower and 31 more locationsSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: July 27, 2021
Recruitment status
Completed
Enrollment listed in the registry
212
Sponsor
Bionomics Limited
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States, United Kingdom
Age range
From 18 Years to 75 Years
Official registry ID
NCT04951076
Official title
Show the full official title

A Phase 2b, Randomized, Double Blind, Two Arm Study to Investigate the Effects of BNC210 Tablet Formulation Compared to Placebo in Adults With Post-Traumatic Stress Disorder (PTSD)

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Bellflower, United States · Beverly Hills, United States · Colton, United States

29 more locations
  • Oceanside, United States
  • Orange, United States
  • Temecula, United States
  • Jacksonville, United States
  • Lauderhill, United States
  • Miami Lakes, United States
  • Orlando, United States
  • Overland Park, United States
  • Prairie Village, United States
  • New Bedford, United States
  • Las Vegas, United States
  • Berlin, United States
  • Cherry Hill, United States
  • Cedarhurst, United States
  • Staten Island, United States
  • North Canton, United States
  • Oklahoma City, United States
  • West Chester, United States
  • Memphis, United States
  • Austin, United States
  • Dallas, United States
  • Draper, United States
  • Barnsley, United Kingdom
  • Blackpool, United Kingdom
  • Cannock, United Kingdom
  • Leeds, United Kingdom
  • Liverpool, United Kingdom
  • Manchester, United Kingdom
  • Stockton-on-Tees, United Kingdom

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What did researchers investigate?

Researchers compared BNC210 and placebo to find out how the approaches affected post-traumatic stress symptoms in adults with PTSD.

Who is behind this study?

The study sponsor is Bionomics Limited.

Did this study involve medication?

Yes. The study involved medication, including BNC210 and Placebo.

Who was this study for?

This study was for people with PTSD. Listed age limits: 18 years to 75 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies